Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting Trypanothione Reductase, a Key Enzyme in the Redox Trypanosomatid Metabolism, to Develop New Drugs against Leishmaniasis and Trypanosomiases
Theo Battista, Gianni Colotti, Andrea Ilari, et al.
Molecules (2020) Vol. 25, Iss. 8, pp. 1924-1924
Open Access | Times Cited: 113

Showing 1-25 of 113 citing articles:

Modulation of the Innate Immune Response by Targeting Toll-like Receptors: A Perspective on Their Agonists and Antagonists
Stefano Federico, Luca Pozzetti, Alessandro Papa, et al.
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 22, pp. 13466-13513
Closed Access | Times Cited: 93
An Overview on Target-Based Drug Design against Kinetoplastid Protozoan Infections: Human African Trypanosomiasis, Chagas Disease and Leishmaniases
Violeta Kourbeli, Eleni Chontzopoulou, Kalliopi Moschovou, et al.
Molecules (2021) Vol. 26, Iss. 15, pp. 4629-4629
Open Access | Times Cited: 66
Current leishmaniasis drug discovery
Alessandra C. Pinheiro, M.V.N. De Souza
RSC Medicinal Chemistry (2022) Vol. 13, Iss. 9, pp. 1029-1043
Open Access | Times Cited: 36
Tackling Sleeping Sickness: Current and Promising Therapeutics and Treatment Strategies
Miebaka Jamabo, Maduma Ernst Mahlalela, Adrienne L. Edkins, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12529-12529
Open Access | Times Cited: 19
Targeting Trypanothione Metabolism in Trypanosomatids
María-Cristina González-Montero, Julia Andrés-Rodríguez, Nerea García-Fernández, et al.
Molecules (2024) Vol. 29, Iss. 10, pp. 2214-2214
Open Access | Times Cited: 8
Molecular Mechanisms of Drug Resistance in Leishmania spp.
María Juliana Moncada-Díaz, Cristian Camilo Rodríguez-Almonacid, Eyson Quiceno-Giraldo, et al.
Pathogens (2024) Vol. 13, Iss. 10, pp. 835-835
Open Access | Times Cited: 8
Metabolic Pathways of Leishmania Parasite: Source of Pertinent Drug Targets and Potent Drug Candidates
Surbhi Jain, Utkarsha Sahu, Awanish Kumar, et al.
Pharmaceutics (2022) Vol. 14, Iss. 8, pp. 1590-1590
Open Access | Times Cited: 25
Targeted Protein Degradation for Infectious Diseases: from Basic Biology to Drug Discovery
Rocío Marisol Espinoza-Chávez, Alessandra Salerno, Anastasia Liuzzi, et al.
ACS Bio & Med Chem Au (2022) Vol. 3, Iss. 1, pp. 32-45
Open Access | Times Cited: 23
Fragment Merging, Growing, and Linking Identify New Trypanothione Reductase Inhibitors for Leishmaniasis
Cécile Exertier, Alessandra Salerno, Lorenzo Antonelli, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 1, pp. 402-419
Open Access | Times Cited: 5
Exploring N-myristoyltransferase as a promising drug target against parasitic neglected tropical diseases
Igor José dos Santos Nascimento, Misael de Azevedo Teotônio Cavalcanti, Ricardo Olímpio de Moura
European Journal of Medicinal Chemistry (2023) Vol. 258, pp. 115550-115550
Closed Access | Times Cited: 11
An In vitro and in silico investigation of the antitrypanosomal activities of the stem bark extracts of Anopyxis klaineana (Pierre) Engl
Latif Adams, Dorcas Obiri-Yeboah, Michael Afiadenyo, et al.
Heliyon (2024) Vol. 10, Iss. 6, pp. e28025-e28025
Open Access | Times Cited: 4
A “Golden Age” for the discovery of new antileishmanial agents: Current status of leishmanicidal gold complexes and prospective targets beyond the trypanothione system
Letícia B. Rosa, Rochanna L. Aires, Laiane dos Santos Oliveira, et al.
ChemMedChem (2021) Vol. 16, Iss. 11, pp. 1682-1696
Closed Access | Times Cited: 26
Small molecules containing chalcogen elements (S, Se, Te) as new warhead to fight neglected tropical diseases
Andreina Henriquez-Figuereo, Cristina Morán-Serradilla, Eduardo Angulo-Elizari, et al.
European Journal of Medicinal Chemistry (2022) Vol. 246, pp. 115002-115002
Open Access | Times Cited: 19
Polyamine Metabolism in Leishmania Parasites: A Promising Therapeutic Target
Nicola S. Carter, Yumena Kawasaki, Surbhi S. Nahata, et al.
Medical Sciences (2022) Vol. 10, Iss. 2, pp. 24-24
Open Access | Times Cited: 18
Molecular targets for Chagas disease: validation, challenges and lead compounds for widely exploited targets
Mariana Laureano de Souza, Thibault Joseph William Jacques Dit Lapierre, Gabriel Marques, et al.
Expert Opinion on Therapeutic Targets (2023) Vol. 27, Iss. 10, pp. 911-925
Closed Access | Times Cited: 10
32nd Annual GP2A Medicinal Chemistry Conference
Jean‐Jacques Hélesbeux, Florence O. McCarthy, Maria Manuel Silva, et al.
Drugs and Drug Candidates (2025) Vol. 4, Iss. 1, pp. 2-2
Open Access
Guanidines Conjugated with Cell-Penetrating Peptides: A New Approach for the Development of Antileishmanial Molecules
João Victor Marcelino de Souza, Natalia C. S. Costa, Maria Carolina Oliveira Arruda Brasil, et al.
Molecules (2025) Vol. 30, Iss. 2, pp. 264-264
Open Access
Leishmaniasis y su Resistencia a Fármacos: Un Enfoque Bibliométrico
César Aníbal Barzola Gaibor
Estudios y Perspectivas Revista Científica y Académica (2025) Vol. 4, Iss. 4, pp. 2464-2512
Closed Access
Natural phytochemicals reverting M2 to M1 macrophages: A novel alternative Leishmaniasis therapy
AP Mohanty, Vasu Vekariya, Shivani Yadav, et al.
Microbial Pathogenesis (2025), pp. 107311-107311
Closed Access
Computational Design of Snake Venom-Derived Peptides as Broad-Spectrum Antiparasitics Targeting Trypanothione Reductase
Áleff Ferreira Francisco, Erika Crhistina Santos de Araújo, Mateus Farias Souza, et al.
(2025)
Closed Access
In Vitro and In Silico Assessment of Antileishmanial Potential of Novel Tri‐ and Penta‐Valent Antimony Complexes With Phenolic Ligands
Syeda Aaliya Shehzadi, Faiz Ahmed, Arshad Islam, et al.
Drug Development Research (2025) Vol. 86, Iss. 1
Closed Access
Recent developments in the treatment of leishmaniasis: Natural compounds, drug targets, in silico molecular docking approaches, and nanocarriers
Nergiz Gürbüz Çolak
Studies in natural products chemistry (2025), pp. 461-494
Closed Access
Kinetoplastid diseases: insights into the mechanisms of drug action and resistance for novel drug discovery
Abdullah M. Tauheed, Ammar Usman Danazumi, Oluwafemi Abiodun Adepoju, et al.
Aspects of Molecular Medicine (2025), pp. 100071-100071
Open Access
Targeting Cysteine Protease B to Discover Antileishmanial Drugs: Directions and Advances
Esteban F. Rios, Sonaly Lima Albino, Ricardo Olímpio de Moura, et al.
European Journal of Medicinal Chemistry (2025) Vol. 289, pp. 117500-117500
Closed Access
Oxidative Imbalance Linked to Impaired Mitochondrial Bioenergetics Mediates the Toxicity of Mesoionic Compounds MI-D and MI-J in Hepatocarcinoma Cells (HepG2)
Ana Paula Neves, Fernando Diego Kaziuk, Marília Locatelli Corrêa-Ferreira, et al.
Free Radical Research (2025), pp. 1-12
Closed Access
Page 1 - Next Page

Scroll to top